Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» labeling
labeling
FDA revises biosimilar guidelines for clearer drug labelling
FDA revises biosimilar guidelines for clearer drug labelling
Pharmaceutical Technology
FDA
biosimilars
labeling
Flag link:
Study: Extrapolation used in more than half of pediatric drug labeling changes
Study: Extrapolation used in more than half of pediatric drug labeling changes
RAPS.org
regulatory
pediatric
extrapolation
labeling
Flag link:
Teva’s generic label not skinny enough to protect from $234M damages to GSK
Teva’s generic label not skinny enough to protect from $234M damages to GSK
MedCity News
Teva Pharmaceutical
generics
labeling
patents
GSK
Coreg
Flag link:
FDA revises labeling of Biogen's Alzheimer's drug to emphasize early treatment
FDA revises labeling of Biogen's Alzheimer's drug to emphasize early treatment
BioPharma Dive
Biogen
Aduhelm
FDA
Alzheimer's disease
labeling
Flag link:
Novartis’ blockbuster heart med Entresto snags FDA approval in larger patient group
Novartis’ blockbuster heart med Entresto snags FDA approval in larger patient group
Fierce Pharma
Novartis
Entresto
heart failure
labeling
FDA
Flag link:
Bristol-Myers, Sanofi ordered to pay Hawaii $834 million over Plavix warning label
Bristol-Myers, Sanofi ordered to pay Hawaii $834 million over Plavix warning label
Reuters
Bristol-Myers Squibb
Sanofi
Plavix
Hawaii
deceptive marketing
labeling
Flag link:
GSK, Teva on-again, off-again lawsuit is back on: Will 'skinny labeling' get a reprieve?
GSK, Teva on-again, off-again lawsuit is back on: Will 'skinny labeling' get a reprieve?
Fierce Pharma
GSK
generics
skinny labels
labeling
Teva Pharmaceutical
Flag link:
FDA goes beyond the label to educate doctors—and enlighten others—about new cancer drugs
FDA goes beyond the label to educate doctors—and enlighten others—about new cancer drugs
Fierce Pharma
FDA
physicians
cancer
labeling
Flag link:
What's next for Amarin? CEO John Thero talks Vascepa's label, pricing and future partnerships
What's next for Amarin? CEO John Thero talks Vascepa's label, pricing and future partnerships
Biopharma Dive
Amarin
Vascepa
John Thero
labeling
Flag link:
Drugmakers Seek Clarity on Two FDA Labeling Guidances
Drugmakers Seek Clarity on Two FDA Labeling Guidances
RAPS.org
FDA
labeling
biologics
drug abuse
drug dependence
Flag link:
FDA Drafts Two New Guidances on Drug Labeling
FDA Drafts Two New Guidances on Drug Labeling
RAPS.org
FDA
labeling
drug abuse
IFU
Flag link:
SCOTUS Says Judge, Not Jury, Should Decide Merck Drug Labeling Case
SCOTUS Says Judge, Not Jury, Should Decide Merck Drug Labeling Case
RAPS.org
FDA
Merck
labeling
failure-to-warn
Fosamax
Flag link:
FDA finalizes accelerated approval labeling guidance
FDA finalizes accelerated approval labeling guidance
Endpoints
FDA
labeling
Flag link:
FDA Withdraws Proposed Rule on Generic Label Changes
FDA Withdraws Proposed Rule on Generic Label Changes
RAPS.org
FDA
labeling
generics
Flag link:
Stage Set for Merck’s SCOTUS Case Over Warnings in Labels
Stage Set for Merck’s SCOTUS Case Over Warnings in Labels
RAPS.org
Merck
warnings
labeling
Supreme Court
Flag link:
3 Things Alnylam's Management Wants Investors to Know About the Launch of Onpattro
3 Things Alnylam's Management Wants Investors to Know About the Launch of Onpattro
Motley Fool
Alnylam
Onpattro
hATTR amyloidosis
drug pricing
labeling
Flag link:
Indications and Usage: FDA Issues Draft Labeling Guidance
Indications and Usage: FDA Issues Draft Labeling Guidance
RAPS.org
FDA
labeling
Flag link:
FDA approves label update to Novo Nordisk’s Tresiba diabetes drug
FDA approves label update to Novo Nordisk’s Tresiba diabetes drug
Drug Delivery Business News
FDA
Novo Nordisk
diabetes
Tresiba
labeling
insulin degludec
Flag link:
GSK Announces Positive EU Approval for Labelling Update to Relvar Ellipta in Patients with Asthma
GSK Announces Positive EU Approval for Labelling Update to Relvar Ellipta in Patients with Asthma
Businesswire
GSK
Europe
labeling
Relvar Ellipta
asthma
Flag link:
FDA revises label on opioid cold meds to limit pediatric use
FDA revises label on opioid cold meds to limit pediatric use
Drug Delivery Business News
FDA
opioids
pediatrics
labeling
Flag link:
Pages
1
2
3
next ›
last »